Dyne Therapeutics IncNASDAQ:DYN
- LAST PRICE36.5900
- TODAY'S CHANGE (%)0.1800 (0.4944%)
- Bid / Lots36.0000/ 30
- Ask / Lots36.6900/ 1
- Open / Previous Close36.4800 / 36.4100
- Day Range
- 52 Week Range
- Volume3,413,954
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DYN |
|---|---|---|
| 09:32 ET | 151186 | 36.385 |
| 09:34 ET | 400 | 36.385 |
| 09:36 ET | 829 | 36.755 |
| 09:38 ET | 5594 | 36.98 |
| 09:39 ET | 350 | 36.95 |
| 09:41 ET | 762 | 36.9 |
| 09:43 ET | 200 | 36.88 |
| 09:45 ET | 6066 | 36.365 |
| 09:48 ET | 400 | 36.345 |
| 09:50 ET | 1416 | 36.32 |
| 09:52 ET | 3367 | 36.3 |
| 09:54 ET | 646 | 36.24 |
| 09:56 ET | 2399 | 36.1 |
| 09:59 ET | 200 | 36.22 |
| 10:01 ET | 1788 | 36.39 |
| 10:03 ET | 903 | 36.45 |
| 10:06 ET | 1000 | 36.41 |
| 10:08 ET | 1316 | 36.5 |
| 10:10 ET | 1125 | 36.58 |
| 10:12 ET | 1590 | 36.64 |
| 10:14 ET | 653 | 36.6 |
| 10:15 ET | 1165 | 36.55 |
| 10:17 ET | 1427 | 36.55 |
| 10:19 ET | 1600 | 36.615 |
| 10:21 ET | 200 | 36.559073 |
| 10:24 ET | 600 | 36.59 |
| 10:26 ET | 1603 | 36.575 |
| 10:28 ET | 2713 | 36.655 |
| 10:30 ET | 12745 | 36.785 |
| 10:32 ET | 5485 | 36.66 |
| 10:33 ET | 1387 | 36.655 |
| 10:35 ET | 5096 | 36.725 |
| 10:37 ET | 6466 | 36.8 |
| 10:39 ET | 3680 | 36.84 |
| 10:42 ET | 6648 | 36.67 |
| 10:44 ET | 5840 | 36.67 |
| 10:46 ET | 3377 | 36.72 |
| 10:48 ET | 8006 | 36.82 |
| 10:50 ET | 9411 | 36.565 |
| 10:51 ET | 2665 | 36.7 |
| 10:53 ET | 9861 | 36.625 |
| 10:55 ET | 5567 | 36.79 |
| 10:57 ET | 2930 | 36.975 |
| 11:00 ET | 6598 | 36.99 |
| 11:02 ET | 5639 | 36.985 |
| 11:04 ET | 10260 | 36.65 |
| 11:06 ET | 1400 | 36.84 |
| 11:08 ET | 8698 | 36.84 |
| 11:09 ET | 4409 | 36.7 |
| 11:11 ET | 3364 | 36.76 |
| 11:13 ET | 7547 | 36.83 |
| 11:15 ET | 2100 | 36.97 |
| 11:18 ET | 9123 | 36.765 |
| 11:20 ET | 11155 | 36.58 |
| 11:22 ET | 4232 | 36.66 |
| 11:24 ET | 2821 | 36.535 |
| 11:26 ET | 6802 | 36.49 |
| 11:27 ET | 7399 | 36.37 |
| 11:29 ET | 2996 | 36.27 |
| 11:31 ET | 5593 | 36.11 |
| 11:33 ET | 12130 | 36.09 |
| 11:36 ET | 2294 | 36.026298 |
| 11:38 ET | 8324 | 36.065 |
| 11:40 ET | 16569 | 36.1 |
| 11:42 ET | 6326 | 36.035 |
| 11:44 ET | 5559 | 36.11 |
| 11:45 ET | 8785 | 36.3 |
| 11:47 ET | 2400 | 36.31 |
| 11:49 ET | 4499 | 36.23 |
| 11:51 ET | 4244 | 36.13 |
| 11:54 ET | 1148 | 36.15 |
| 11:56 ET | 4174 | 36.12 |
| 11:58 ET | 6846 | 36.53 |
| 12:00 ET | 2225 | 36.465 |
| 12:02 ET | 6156 | 36.41 |
| 12:03 ET | 4274 | 36.39 |
| 12:05 ET | 3678 | 36.34 |
| 12:07 ET | 4794 | 36.32 |
| 12:09 ET | 5892 | 36.45 |
| 12:12 ET | 1963 | 36.455 |
| 12:14 ET | 6460 | 36.36 |
| 12:16 ET | 7081 | 36.225 |
| 12:18 ET | 1200 | 36.31 |
| 12:20 ET | 4862 | 36.28 |
| 12:21 ET | 6460 | 36.3 |
| 12:23 ET | 2769 | 36.375 |
| 12:25 ET | 3463 | 36.4 |
| 12:27 ET | 5569 | 36.41 |
| 12:30 ET | 2975 | 36.43 |
| 12:32 ET | 8321 | 36.255 |
| 12:34 ET | 5512 | 36.235 |
| 12:36 ET | 1700 | 36.19 |
| 12:38 ET | 5048 | 36.18 |
| 12:39 ET | 7018 | 36.065 |
| 12:41 ET | 2800 | 36.1052 |
| 12:43 ET | 5710 | 36.2 |
| 12:45 ET | 9407 | 36.14 |
| 12:48 ET | 6316 | 36.14 |
| 12:50 ET | 2367 | 36.16 |
| 12:52 ET | 5310 | 36.23 |
| 12:54 ET | 5580 | 36.21 |
| 12:56 ET | 1977 | 36.265 |
| 12:57 ET | 6881 | 36.16 |
| 12:59 ET | 6339 | 36.09 |
| 01:01 ET | 1634 | 36.105 |
| 01:03 ET | 8123 | 36.13 |
| 01:06 ET | 7904 | 36.165 |
| 01:08 ET | 2425 | 36.205 |
| 01:10 ET | 4306 | 36.32 |
| 01:12 ET | 6853 | 36.27 |
| 01:14 ET | 3036 | 36.3 |
| 01:15 ET | 4895 | 36.32 |
| 01:17 ET | 7319 | 36.26 |
| 01:19 ET | 2171 | 36.3 |
| 01:21 ET | 8676 | 36.49 |
| 01:24 ET | 8073 | 36.27 |
| 01:26 ET | 1700 | 36.305 |
| 01:28 ET | 6404 | 36.32 |
| 01:30 ET | 7905 | 36.37 |
| 01:32 ET | 2005 | 36.365 |
| 01:33 ET | 5352 | 36.44 |
| 01:35 ET | 7973 | 36.445 |
| 01:37 ET | 4236 | 36.545 |
| 01:39 ET | 5023 | 36.56 |
| 01:42 ET | 5702 | 36.365 |
| 01:44 ET | 1979 | 36.375 |
| 01:46 ET | 5758 | 36.39 |
| 01:48 ET | 5208 | 36.21 |
| 01:50 ET | 2725 | 36.25 |
| 01:51 ET | 5207 | 36.31 |
| 01:53 ET | 5398 | 36.26 |
| 01:55 ET | 2229 | 36.33 |
| 01:57 ET | 5695 | 36.26 |
| 02:00 ET | 6682 | 36.25 |
| 02:02 ET | 1725 | 36.275 |
| 02:04 ET | 6330 | 36.31 |
| 02:06 ET | 7909 | 36.24 |
| 02:08 ET | 2200 | 36.305 |
| 02:09 ET | 4844 | 36.35 |
| 02:11 ET | 5504 | 36.265 |
| 02:13 ET | 4167 | 36.37 |
| 02:15 ET | 4550 | 36.535 |
| 02:18 ET | 6117 | 36.495 |
| 02:20 ET | 3125 | 36.43 |
| 02:22 ET | 6249 | 36.46 |
| 02:24 ET | 7917 | 36.4 |
| 02:26 ET | 2741 | 36.37 |
| 02:27 ET | 6977 | 36.37 |
| 02:29 ET | 6630 | 36.325 |
| 02:31 ET | 6164 | 36.34 |
| 02:33 ET | 6482 | 36.425 |
| 02:36 ET | 4417 | 36.43 |
| 02:38 ET | 5950 | 36.5 |
| 02:40 ET | 8012 | 36.52 |
| 02:42 ET | 62874 | 36.45 |
| 02:44 ET | 10143 | 36.53 |
| 02:45 ET | 6336 | 36.61 |
| 02:47 ET | 7603 | 36.615 |
| 02:49 ET | 8130 | 36.55 |
| 02:51 ET | 4403 | 36.635 |
| 02:54 ET | 6542 | 36.615 |
| 02:56 ET | 5410 | 36.74 |
| 02:58 ET | 4895 | 36.77 |
| 03:00 ET | 6313 | 36.735 |
| 03:02 ET | 7621 | 36.73 |
| 03:03 ET | 2617 | 36.79 |
| 03:05 ET | 7098 | 36.72 |
| 03:07 ET | 10943 | 36.65 |
| 03:09 ET | 1405 | 36.56 |
| 03:12 ET | 6574 | 36.5 |
| 03:14 ET | 6020 | 36.455 |
| 03:16 ET | 3022 | 36.575 |
| 03:18 ET | 4763 | 36.55 |
| 03:20 ET | 5030 | 36.49 |
| 03:21 ET | 2407 | 36.65 |
| 03:23 ET | 4572 | 36.63 |
| 03:25 ET | 6373 | 36.5561 |
| 03:27 ET | 3372 | 36.545 |
| 03:30 ET | 14136 | 36.56 |
| 03:32 ET | 5259 | 36.52 |
| 03:34 ET | 3651 | 36.59 |
| 03:36 ET | 9526 | 36.52 |
| 03:38 ET | 7923 | 36.53 |
| 03:39 ET | 6605 | 36.605 |
| 03:41 ET | 6749 | 36.515 |
| 03:43 ET | 7935 | 36.37 |
| 03:45 ET | 1447 | 36.405 |
| 03:48 ET | 9357 | 36.33 |
| 03:50 ET | 5624 | 36.2575 |
| 03:52 ET | 45838 | 36.41 |
| 03:54 ET | 14297 | 36.725 |
| 03:56 ET | 25054 | 36.72 |
| 03:57 ET | 18926 | 36.54 |
| 03:59 ET | 1644657 | 36.59 |
Today
Bragar Eagel & Squire, P.C. Is Investigating Dyne, Napco, and Franklin and Encourages Investors to Contact the Firm, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesDyne Therapeutics Inc May Have Engaged In Securities Fraud And The Schall Law Firm Wants Shareholders To Contribute To An Investigation, from 11 hours ago by Dow Jones
11 hours ago by Dow Jones
Yesterday
Investors Are Urged To Join The Schall Law Firm In An Inquiry Into Dyne Therapeutics, Inc. For Securities Law Violations, from 11:04AM ET on Thursday Sep 19, 2024 by Dow Jones
11:04AM ET on Thursday Sep 19, 2024 by Dow JonesBronstein, Gewirtz & Grossman, LLC Encourages Dyne Therapeutics, Inc. (DYN) Shareholders to Inquire about Securities Investigation, from 10:01AM ET on Thursday Sep 19, 2024 by Dow Jones
10:01AM ET on Thursday Sep 19, 2024 by Dow Jones
Sep 18, 2024
Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And The Schall Law Firm Wants Impacted Shareholders To Reach Out, from 11:01AM ET on Wednesday Sep 18, 2024 by Dow Jones
11:01AM ET on Wednesday Sep 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Dyne Therapeutics Inc | 3.7B | -10.2x | --- |
Biohaven Ltd | 3.8B | -4.4x | --- |
MoonLake Immunotherapeutics | 3.4B | -59.8x | --- |
Merus NV | 3.5B | -17.3x | --- |
Iovance Biotherapeutics Inc | 3.1B | -6.0x | --- |
Apogee Therapeutics Inc | 3.1B | -26.0x | --- |
Company Information
Dyne Therapeutics Inc. is a clinical-stage muscle disease company. It is focused on advancing life-transforming therapeutics for people living with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. Its FORCE platform therapeutics consist of an oligonucleotide payload that is designed to target the genetic basis of the disease. Using its FORCE platform, it is assembling a portfolio of muscle disease therapeutics, including its lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD), and facioscapulohumeral dystrophy (FSHD). Its therapeutics consist of three components: a Fab, a clinically validated linker, and an oligonucleotide payload that it attaches to its Fab using the linker. It also plans to expand its portfolio through development efforts focused on rare skeletal muscle diseases, as well as cardiac and metabolic muscle diseases.
Contact Information
- Headquarters
- 1560 Trapelo RoadWALTHAM, MA, United States 02451
- Phone
- 781-786-8230
- Fax
- 781-786-8866
Executives
- Independent Chairman of the Board
- Jason Rhodes
- President, Chief Executive Officer, Director
- John Cox
- Chief Operating Officer
- Susanna High
- Chief Human Resource Officer
- Lucia Celona
- Senior Vice President, Head of Finance and Administration
- Richard Scalzo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.7B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 100.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.07 |
EPS | $-3.58 |
Book Value | $1.49 |
P/E Ratio | -10.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
